Theratechnologies Inc (NAS:THTX)
$ 1.3 0 (0%) Market Cap: 60.06 Mil Enterprise Value: 81.21 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Q1 2022 Theratechnologies Inc Earnings Call Transcript

Apr 13, 2022 / 12:30PM GMT
Release Date Price: $10.36 (+3.19%)
Operator

Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Theratechnologies First Quarter Fiscal Year 2020 Earnings Conference Call.

(Operator Instructions)

I would like to remind everyone that this conference call is being recorded today, Wednesday, April 13, 2022 at 8:30 a.m. Eastern Time. I will now turn the call over to John Mullaly, LifeSci Advisors. Mr. Mullaly, please go ahead.

John Mullaly
LifeSci Advisors, LLC - MD

Thank you, and welcome. Mr. Paul Lévesque, President and Chief Executive Officer of Theratechnologies; and Mr. Philippe Dubuc, Senior Vice President and Chief Financial Officer, will be the speakers on today's call. Additionally, Theratechnologies has also asked Christian Marsolais, Chief Medical Officer, to participate on today's call to provide an update in regard to the progress of TH1902, the company's lead oncology asset.

Now before Paul begins his remarks, I have been asked by Theratechnologies to read the following messages regarding forward-looking statements. I would like to remind

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot